Thu, Jul 24, 2014, 7:55 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

AMPIO PHARMACEUTICAL Message Board

  • stock.gainer13 stock.gainer13 Mar 8, 2011 12:10 PM Flag

    FDA PLAY// LOW FLOAT (46M), 3 CATALYSTS, 500M MCAP, 200M CASH ON HAND, TAKEOVER TARGET BY BIG PHARMA

     

    BLOCKBUSTER DRUG Fidaxomicin, BILLION DOLLAR MARKET CAP POTENTIAL!!
    TAKEOVER TARGET BY BIG PHARMA!!

    Optimer (OPTR) is developing the 1st drug in 25 years to treat C. diff, an infection responsible killing many hospital patients every year. The disease is difficult to treat with current therapy due to high recurrence rate. Fidaxomicin decreases recurrence rate by > 45% vs. standard treatment.


    Catalyst 1: FDA Panel Vote on 4/5/2011

    Catalyst 2: PDUFA on 5/30/2011

    Catalyst 3: Europe Approval 2H 2011


    Optimer Pharmaceuticals (OPTR) Low float: 46M shares outstanding; Cash on Hand: $200M.

    Already partnered in EUROPE - $224 Million Dollar Deal w/ double digit royalties

    BUY Optimer Pharmaceuticals (OPTR), or pay more later!!

    e52yeyeywy

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMPE
6.34-0.05(-0.78%)Jul 24 4:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.